Pure Biologics S.A.
ISIN: PLPRBLG00010 | Ticker: PUR | LEI: 2594002TXS19AUYHIF82
Country: Poland
Pure Biologics is a biopharmaceutical company focused on the biological drug and non-systemic therapies discovery and development. We operate in the areas of immuno-oncology, autoimmunology, and rare neurological diseases, conducting research based on our own technology platforms for the selection of active molecules – antibodies and aptamers.
Pure Biologics also offers commercial partnership options in several areas including early phase biological drug discovery and development, selection and characterization of antibodies and aptamers, as well as protein production, purification and analysis.
2010
Served areaWorldwide
HeadquartersDuńska 11, 54-427 Wrocław – Poland
PLPRBLG00010
LEI2594002TXS19AUYHIF82
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.